Cirrhosis Research-2011 Apr

Cirrhosis Research-2011 Apr

In 2011, Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model in mice. BACKGROUND: Investigated the effects of cannabidiol, a non-psychoactive constituent of Cannabis sativawith anti-inflammatory properties that activates the 5-hydroxytryptamine receptor 5-HT1A, on brain and liver functions in a model of hepatic encephalopathy associated with fulminant hepatic failure induced in mice by thioacetamide. .. Read More

Cirrhosis Research-2011 Jun

In 2011, In this study, we find that CBD a major non-psychoactive component of the plant Cannabis sativa, selectively kills activated hepatic stellate cells through the previously unexplored mechanism of ER stress. Background:  We provide a molecular basis of action for CBD and identify CBD as a novel potential therapeutic agent for liver fibrosis. You can read .. Read More